JOINN Laboratories (China) Co., Ltd. (6127) has scheduled a board meeting on 30 October 2025 to consider and approve the third quarterly results for the nine months ended 30 September 2025. These results are expected to be released following the board’s approval.
According to the announcement dated 17 October 2025, key matters for deliberation include the review of third-quarter financial performance and other related discussions.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.